Screener
Collegium Pharmaceutical, Inc. COLL Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Collegium Pharmaceutical, Inc.’s reported figures.
The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:34 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053851
FAQ
- What is Collegium Pharmaceutical, Inc.'s invested capital?
- Collegium Pharmaceutical, Inc. (COLL) reported invested capital of $166.5M in Q2 2026.
- How has Collegium Pharmaceutical, Inc.'s invested capital changed year-over-year?
- Collegium Pharmaceutical, Inc.'s invested capital increased by 66.3% year-over-year, from $100.15M to $166.5M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s invested capital has grown at a 20.8% compound annual growth rate (CAGR), from $21.41M to $55.06M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Collegium Pharmaceutical, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude